z-logo
Premium
Synthesis of nevirapine and its major metabolite
Author(s) -
Grozinger K. G.,
Fuchs V.,
Hargrave K. D.,
Mauldin S.,
Vitous J.,
Campbell S.,
Adams J.
Publication year - 1995
Publication title -
journal of heterocyclic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.321
H-Index - 59
eISSN - 1943-5193
pISSN - 0022-152X
DOI - 10.1002/jhet.5570320144
Subject(s) - nevirapine , chemistry , metabolite , hydroxymethyl , aldehyde , reverse transcriptase inhibitor , nucleoside , stereochemistry , reverse transcriptase , combinatorial chemistry , human immunodeficiency virus (hiv) , organic chemistry , biochemistry , virology , viral load , antiretroviral therapy , biology , rna , gene , catalysis
Several synthetic methods were developed during the process optimization for the large scale synthesis of nevirapine ( 1 ), a non‐nucleoside inhibitor of HIV‐1 Reverse Transcriptase. The synthesis of its putative major metabolite 11‐cyclopropyl‐5,11‐dihydro‐4‐hydroxymethyl‐6 H ‐[3,2‐ b :2′,3′‐ e ][1,4]diazepin‐6‐one ( 2 ) and the oxidation of 2 to the corresponding aldehyde 3 , are described.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom